Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

The Immune Checkpoint Kick Start: Optimization of Neoadjuvant Combination Therapy Using Game Theory.

West J, Robertson-Tessi M, Luddy K, Park DS, Williamson DFK, Harmon C, Khong HT, Brown J, Anderson ARA.

JCO Clin Cancer Inform. 2019 Feb;(3):1-12. doi: 10.1200/CCI.18.00078.

2.

Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies.

Gallaher JA, Enriquez-Navas PM, Luddy KA, Gatenby RA, Anderson ARA.

Cancer Res. 2018 Apr 15;78(8):2127-2139. doi: 10.1158/0008-5472.CAN-17-2649. Epub 2018 Jan 30.

PMID:
29382708
3.

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival.

Poleszczuk J, Luddy K, Chen L, Lee JK, Harrison LB, Czerniecki BJ, Soliman H, Enderling H.

Breast Cancer Res. 2017 Jun 30;19(1):75. doi: 10.1186/s13058-017-0870-1.

4.

Tris-base buffer: a promising new inhibitor for cancer progression and metastasis.

Ibrahim-Hashim A, Abrahams D, Enriquez-Navas PM, Luddy K, Gatenby RA, Gillies RJ.

Cancer Med. 2017 Jul;6(7):1720-1729. doi: 10.1002/cam4.1032. Epub 2017 May 29.

5.

Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions.

Poleszczuk JT, Luddy KA, Prokopiou S, Robertson-Tessi M, Moros EG, Fishman M, Djeu JY, Finkelstein SE, Enderling H.

Cancer Res. 2016 Mar 1;76(5):1009-18. doi: 10.1158/0008-5472.CAN-15-1423. Epub 2016 Feb 1.

6.

Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy.

Pilon-Thomas S, Kodumudi KN, El-Kenawi AE, Russell S, Weber AM, Luddy K, Damaghi M, Wojtkowiak JW, Mulé JJ, Ibrahim-Hashim A, Gillies RJ.

Cancer Res. 2016 Mar 15;76(6):1381-90. doi: 10.1158/0008-5472.CAN-15-1743. Epub 2015 Dec 30. Erratum in: Cancer Res. 2017 May 1;77(9):2552.

7.

Transforming growth factor β signaling overcomes dasatinib resistance in lung cancer.

Gordian E, Li J, Pevzner Y, Mediavilla-Varela M, Luddy K, Ohaegbulam K, Daniel KG, Haura EB, Muñoz-Antonia T.

PLoS One. 2014 Dec 11;9(12):e114131. doi: 10.1371/journal.pone.0114131. eCollection 2014.

8.

The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition.

Luddy KA, Robertson-Tessi M, Tafreshi NK, Soliman H, Morse DL.

Front Immunol. 2014 Oct 20;5:429. doi: 10.3389/fimmu.2014.00429. eCollection 2014. Review.

9.

Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth.

Mediavilla-Varela M, Luddy K, Noyes D, Khalil FK, Neuger AM, Soliman H, Antonia SJ.

Cancer Biol Ther. 2013 Sep;14(9):860-8. doi: 10.4161/cbt.25643. Epub 2013 Jul 17.

10.
11.

Cage escape competes with geminate recombination during alkane hydroxylation by the diiron oxygenase AlkB.

Austin RN, Luddy K, Erickson K, Pender-Cudlip M, Bertrand E, Deng D, Buzdygon RS, van Beilen JB, Groves JT.

Angew Chem Int Ed Engl. 2008;47(28):5232-4. doi: 10.1002/anie.200801184. No abstract available.

12.

The diagnostic substrate bicyclohexane reveals a radical mechanism for bacterial cytochrome P450 in whole cells.

Austin RN, Deng D, Jiang Y, Luddy K, van Beilen JB, Ortiz de Montellano PR, Groves JT.

Angew Chem Int Ed Engl. 2006 Dec 11;45(48):8192-4. No abstract available.

PMID:
17103473

Supplemental Content

Support Center